NCT07825831 AI-Assisted Personalized Heat-Risk Alerts
| NCT ID | NCT07825831 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Medical Sciences, Pakistan |
| Condition | Heat-related Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2026-10-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-09-01 with a primary completion date of 2026-10-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This two-arm randomized controlled trial will evaluate whether an artificial intelligence-assisted personalized heat-risk alert system reduces heat-related illness symptom burden among adults with chronic conditions. The intervention will integrate prespecified clinical characteristics with the Pakistan Meteorological Department's same-day forecast maximum temperature to classify individual heat-related acute clinical-event risk and deliver personalized alerts through a mobile application. The control group will receive a generic PMD heat-health advisory through the same application.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older attending the outpatient department of the selected tertiary-care hospital during the recruitment period. * Have a documented diagnosis of at least one chronic non-communicable disease associated with increased susceptibility to heat-related illness, including hypertension, type 2 diabetes mellitus, chronic kidney disease, cardiovascular disease, or obesity (BMI ≥30 kg/m²). * Have access to a personal smartphone capable of receiving study heat-risk alert notifications. * Be able to read Urdu or English, or have a household member/caregiver available to read and explain study alerts when required. * Be willing and able to provide written informed consent. * Intend to remain within the study catchment area for the duration of the six-week study period to facilitate follow-up. Exclusion Criteria: * Patients requiring immediate emergency treatment or hospital admission at the time of recruitment. * Individuals with severe cognitive impairment, dementia, psychotic illness, or another medical condition that limits their ability to understand study procedures or provide informed consent. * Patients with terminal illness or those receiving palliative care. * Individuals with severe visual, hearing, or communication impairments that prevent effective receipt of the study alert intervention and outcome assessment without a reliable caregiver. * Pregnant women, because pregnancy has distinct physiological responses to heat exposure and would require separate clinical risk stratification beyond the scope of this study. * Participants currently enrolled in another clinical trial or structured behavioral intervention related to heat-health, climate adaptation, or chronic disease self-management. * Participants who are unable or unwilling to comply with study procedures or complete the required follow-up assessment.
Contact & Investigator
Shamaila Mohsin, PhD Public Health
PRINCIPAL INVESTIGATOR
Armed Forces Post Graduate Medical Institute, AFPGMI, NUMS, Rawalpindi
Frequently Asked Questions
Who can join the NCT07825831 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heat-related Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07825831 currently recruiting?
Yes, NCT07825831 is actively recruiting participants. Contact the research team at mubranoor111@gmail.com for enrollment information.
Where is the NCT07825831 trial being conducted?
This trial is being conducted at Gujranwala, Pakistan.
Who is sponsoring the NCT07825831 clinical trial?
NCT07825831 is sponsored by National University of Medical Sciences, Pakistan. The principal investigator is Shamaila Mohsin, PhD Public Health at Armed Forces Post Graduate Medical Institute, AFPGMI, NUMS, Rawalpindi. The trial plans to enroll 120 participants.